endovasculares.es
Noticias
- Título: American Heart Association launches Center of Excellence accreditation for hospitals offering advanced treatment for heart disease
- Fecha: 09-01-2017
Hospitals receive AHA/ACC evidence-based guidance in treating the most complex heart patients
DALLAS, Dec. 27, 2016 – Beginning Jan. 1, 2017, the American Heart Association (AHA) will offer advanced accreditation for hospitals that meet the high standards needed for treating the most complex cases of heart disease. The Cardiovascular Center of Excellence designation is part of the association’s new accreditation collaboration with the American College of Cardiology (ACC).
The Cardiovascular Center of Excellence designation is an overarching accreditation aimed at meeting all the care needs of the most complex cardiac patients by integrating the most current research for treatment and prevention of cardiac diseases. Backed by the expertise of nationally recognized AHA/ACC accreditation resources, these hospitals will offer the broad scope of cardiovascular care services required to diagnose, treat, rehabilitate, support, and educate patients needing advanced heart disease care.
As a Cardiovascular Center of Excellence, a hospital will commit to, among other things:
- Promote increased participation in care decisions by patients and family members.
- Inform patients about clinical research studies and trial options.
- Collaborate with communities to provide cardiac prevention and educational events.
- Focus on a system of care that ensures optimal treatment and outcomes.
- Improve quality, care coordination and compliance with national care guidelines.
Accredited programs gain local and national exposure through AHA/ACC marketing efforts and the “Find an Accredited Cardiovascular Center Near You” tool, ensuring to patients and providers that accredited hospitals demonstrate adherence to national performance measures.
As with other AHA/ACC quality improvement and accreditation programs, Cardiovascular Centers of Excellence will provide extensive data on patients treated within the facility to use for internal quality improvement, administration, and research. Hospitals can also submit proposals to participate in research studies developed to address important issues in cardiovascular care treatments and outcomes.
Accreditation for Cardiovascular Center of Excellence will provide a framework to high performing hospitals offering wide-ranging cardiovascular services to elevate their standards of performance and provide coordinated, high-quality patient-centered care to the communities they serve.
Accredited organizations will demonstrate the ability to provide comprehensive care to cardiovascular patients through well-organized systems, services, facilities, and highly trained and experienced physicians and cardiovascular teams with an emphasis on delivering quality care and positive patient outcomes.
Learn more about Cardiovascular Centers of Excellence at heart.org/cardiacaccreditation and about the new AHA/ACC accreditation collaboration at cardiacaccreditation.org.
###
About the American Heart Association
The American Heart Association is devoted to saving people from heart disease and stroke – two of the leading causes of death in the world. We team with millions of volunteers to fund innovative research, fight for stronger public health policies, and provide lifesaving tools and information to prevent and treat these diseases. The Dallas-based association is one of the world’s oldest and largest voluntary organizations dedicated to fighting heart disease and stroke. To learn more or to get involved, visit www.heart.org or follow us on Facebook and Twitter.
The American Heart Association/American Stroke Association receives funding mostly from individuals. Foundations and corporations donate as well, and fund specific programs and events. Strict policies are enforced to prevent these relationships from influencing the association’s science content. Financial information for the American Heart Association, including a list of contributions from pharmaceutical companies and device manufacturers, is available at www.heart.org/corporatefunding.
For Media Inquiries: (214) 706-1173
Cathy Lewis: (214) 706-1324; cathy.lewis@heart.org
Julie Del Barto (broadcast): (214) 706-1330; julie.delbarto@heart.org
For Public Inquiries: (800)-AHA-USA1 (242-8721)
- Fuente: endovascular.es
@2011 endovascular. Última actualización: 31-03-2014
